Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  TherapeuticsMD Inc    TXMD

THERAPEUTICSMD INC (TXMD)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/15/2017 11/16/2017 11/17/2017 11/20/2017 11/21/2017 Date
5.97(c) 5.9(c) 5.85(c) 5.9(c) 5.99(c) Last
2 174 148 4 514 666 2 672 938 2 055 908 4 127 754 Volume
+1.70% -1.17% -0.85% +0.85% +1.53% Change
More quotes
Financials ($)
Sales 2017 17,8 M
EBIT 2017 -68,4 M
Net income 2017 -75,6 M
Finance 2017 135 M
Yield 2017 -
Sales 2018 38,8 M
EBIT 2018 -91,5 M
Net income 2018 -89,4 M
Finance 2018 35,2 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 65,2x
EV / Sales2018 32,5x
Capitalization 1 296 M
More Financials
Company
TherapeuticsMD, Inc. is a healthcare company, which focuses on developing and commercializing products for women.Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration... 
Sector
Pharmaceuticals
Calendar
02/22Earnings Release
More about the company
Surperformance© ratings of TherapeuticsMD Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on THERAPEUTICSMD INC
11/16 THERAPEUTICSMD : Announces Third Quarter 2017 Financial Results
11/16 THERAPEUTICSMD : Announces Plan to Resubmit the New Drug Application for TX-004H..
11/13 THERAPEUTICSMD, INC. : Regulation FD Disclosure, Financial Statements and Exhibi..
11/07 THERAPEUTICSMD : to Present at Two Upcoming Investor Conferences
11/07 THERAPEUTICSMD : Management's Discussion and Analysis of Financial Condition and..
11/07 BIOTECH MOVERS : Collegium Pharmaceutical, Inc. (NASDAQ:COLL) and TherapeuticsMD..
11/06 THERAPEUTICSMD : Jumps on NDA Re-Submission, Better-Than-Expected Quarter
11/06 THERAPEUTICSMD : reports 3Q loss
11/06 THERAPEUTICSMD, INC. : Results of Operations and Financial Condition, Regulation..
11/06 THERAPEUTICSMD : Announces Third Quarter 2017 Financial Results
More news
Sector news : Specialty & Advanced Pharmaceuticals
09:50a U.S. FDA approves first two-drug HIV regimen in win for GSK
11/21 Brexit gets real for drugmakers as regulator moves to Amsterdam
11/21 Exclusive - Prescient messages about Indian companies circulate in WhatsApp g..
11/20 ASTRAZENECA : EU drugs agency move to Amsterdam minimizes likely staff losses
11/20 ASTRAZENECA : EU drugs agency move to Amsterdam minimises likely staff losses
More sector news : Specialty & Advanced Pharmaceuticals
News from SeekingAlpha
11/07 YOUR DAILY PHARMA SCOOP : Anxious Time For Dynavax Longs, VBL Therapeutics Gets ..
11/07 TherapeuticsMD Gets Lift From FDA Leniency
11/06 BIOTECH FORUM DAILY DIGEST : Why Adamas Is Soaring
11/06 TherapeuticsMD's (TXMD) CEO Robert Finizio on Q3 2017 Results - Earnings Call..
11/06 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
Chart THERAPEUTICSMD INC
Duration : Period :
TherapeuticsMD Inc Technical Analysis Chart | TXMD | US88338N1072 | 4-Traders
Technical analysis trends THERAPEUTICSMD INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 13,8 $
Spread / Average Target 131%
EPS Revisions
Managers
NameTitle
Tommy George Thompson Chairman
Angus C. Russell Independent Director
J. Martin Carroll Independent Director
C. Christine Miller Chief Compliance & Regulatory Officer
Sector and Competitors
1st jan.Capitalization (M$)
THERAPEUTICSMD INC1.39%1 296
ABBVIE49.49%150 929
MERCK KGAA-8.66%13 793
KYOWA HAKKO KIRIN CO LTD30.41%10 850
JAZZ PHARMACEUTICALS PLC22.78%8 225
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD42.96%6 220